End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20 PEN | 0.00% |
|
0.00% | +41.84% |
Apr. 29 | Bayer S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 06 | Bayer S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 206.1 | 206.1 | 207.6 | 207.6 | 207.6 | 207.6 |
Enterprise Value (EV) 1 | 178.5 | 174.2 | 183.2 | 228.7 | 264.3 | 239.7 |
P/E ratio | 5.44 x | 8.37 x | 5.61 x | 10.2 x | 7.81 x | 17.2 x |
Yield | - | - | 173% | - | - | - |
Capitalization / Revenue | 0.61 x | 0.71 x | 0.63 x | 0.54 x | 0.55 x | 0.62 x |
EV / Revenue | 0.53 x | 0.6 x | 0.56 x | 0.6 x | 0.7 x | 0.71 x |
EV / EBITDA | 3.78 x | 6 x | 3.55 x | 6.03 x | 5.72 x | 10.3 x |
EV / FCF | -89.6 x | 23 x | -11.7 x | 0.7 x | -6.84 x | 9.78 x |
FCF Yield | -1.12% | 4.35% | -8.54% | 142% | -14.6% | 10.2% |
Price to Book | 0.51 x | 0.48 x | 0.44 x | 1.62 x | 1.34 x | 1.25 x |
Nbr of stocks (in thousands) | 14,724 | 14,724 | 14,724 | 14,724 | 14,724 | 14,724 |
Reference price 2 | 14.00 | 14.00 | 14.10 | 14.10 | 14.10 | 14.10 |
Announcement Date | 3/8/19 | 7/27/20 | 3/29/21 | 3/31/22 | 3/31/23 | 3/27/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 338 | 291.6 | 327.9 | 381.4 | 376.2 | 337.5 |
EBITDA 1 | 47.28 | 29.04 | 51.58 | 37.93 | 46.21 | 23.28 |
EBIT 1 | 46.07 | 28.19 | 50.76 | 36.77 | 45.21 | 21.89 |
Operating Margin | 13.63% | 9.67% | 15.48% | 9.64% | 12.02% | 6.49% |
Earnings before Tax (EBT) 1 | 53.54 | 38.15 | 55.41 | 35.28 | 43.96 | 17.51 |
Net income 1 | 37.89 | 24.63 | 37 | 20.26 | 26.58 | 12.04 |
Net margin | 11.21% | 8.45% | 11.28% | 5.31% | 7.07% | 3.57% |
EPS 2 | 2.573 | 1.673 | 2.513 | 1.376 | 1.805 | 0.8178 |
Free Cash Flow 1 | -1.991 | 7.574 | -15.65 | 325.4 | -38.62 | 24.5 |
FCF margin | -0.59% | 2.6% | -4.77% | 85.33% | -10.26% | 7.26% |
FCF Conversion (EBITDA) | - | 26.08% | - | 857.97% | - | 105.23% |
FCF Conversion (Net income) | - | 30.75% | - | 1,606.54% | - | 203.47% |
Dividend per Share | - | - | 24.45 | - | - | - |
Announcement Date | 3/8/19 | 7/27/20 | 3/29/21 | 3/31/22 | 3/31/23 | 3/27/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 21.1 | 56.7 | 32.1 |
Net Cash position 1 | 27.6 | 31.9 | 24.4 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | 0.556 x | 1.227 x | 1.379 x |
Free Cash Flow 1 | -1.99 | 7.57 | -15.7 | 325 | -38.6 | 24.5 |
ROE (net income / shareholders' equity) | 9.76% | 5.89% | 8.24% | 6.81% | 18.8% | 7.51% |
ROA (Net income/ Total Assets) | 6.49% | 3.75% | 6.23% | 5.83% | 10.8% | 5.05% |
Assets 1 | 584.2 | 657.4 | 594.4 | 347.3 | 246.9 | 238.6 |
Book Value Per Share 2 | 27.60 | 29.20 | 31.80 | 8.680 | 10.50 | 11.30 |
Cash Flow per Share 2 | 1.880 | 2.820 | 2.010 | 0.8200 | 0.9600 | 0.5600 |
Capex 1 | 1.22 | 1.47 | 1.13 | 4.25 | 1.79 | 0.79 |
Capex / Sales | 0.36% | 0.5% | 0.34% | 1.11% | 0.48% | 0.23% |
Announcement Date | 3/8/19 | 7/27/20 | 3/29/21 | 3/31/22 | 3/31/23 | 3/27/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+41.84% | 77.6M | |
+9.35% | 79.57B | |
-6.72% | 43.64B | |
+2.94% | 33.11B | |
+14.08% | 18.96B | |
+6.74% | 11.27B | |
-22.78% | 9.96B | |
-10.07% | 9.71B | |
-2.21% | 8.74B | |
-3.60% | 8.46B |
- Stock Market
- Equities
- BAYERI1 Stock
- Financials Bayer S.A. (Peru)